EDC
One size does not fit all
RTSM
Deliver powerful randomization methods
CODER
Fast and accurate clinical coding
Drug and Device Logistics
Mitigate risk and create closer connections throughout the patient journey.
eTMF
Essential document collection made easy
CTMS
Accelerate your trial and ensure data integrity
eCONSENT
Meet patients where they are
eCOA
Faster, cleaner and more reliable data
Patient Poll
Quick insights from patients
eCRF Setup
Capture better data, faster
eTMF Setup
Get up and running in no time
PV Management
Identify and handle your safety management needs
Data Management
Make more informed business decisions
Submission and Data Mapping
Move and consolidate data
eTechnology Strategy
Integrate and capitalize on critical technologies
Protocol Development
Turning your research question into a study
Observational Studies
Digital, cost effective and time efficient
Primary Market Research
Direct to patient, unique, and quality data
IRB and EC Management
End to end regulatory management
PV and GDPR Compliance
Safety, consent and data protection
Scientific Communications
Results dissemination
Digital Communications
Increase patient awareness
Data Linkage
Generate, combine and analyze data
An evidence generation strategy is an advanced plan for generating evidence necessary for all the steps of the product life cycle. Traditionally, research follows consecutive
Save the date on Tuesday November 22th and come to meet our Lise Radoszycki and Andreas Weber at the DMB Annual Conference in Paris! DMB,
When conducting clinical research, double-blind studies are often the chosen experimental design to avoid bias and maximize research validity. A clinical research study, also known
Patient recruitment has often focused on traditional media methods like TV, newspaper, and radio, which often lead to a low recruitment conversion rate. Digital patient
In collaboration with DT Consulting, Carenity*, part of EvidentIQ, conducted a survey of patients whose primary condition was ankylosing spondylitis, bipolar disorder, breast cancer, chronic
In collaboration with DT Consulting, Carenity*, part of EvidentIQ, conducted a survey of patients from France, Germany, Italy, Spain, the UK, and the US to
EvidentIQ Group GmbH Grosse Johannisstr. 7, 20457 Hamburg, Germany.
Copyright 2022 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us:
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister, Franciscus Pijpers
Franciscus Pijpers
Commercial Register
Hamburg, HRB 147319
